Skip to main content

Research Repository

Advanced Search

Response of the porcine MYH4-promoter and MYH4-expressing myotubes to known anabolic and catabolic agents in vitro

Brearley, Madelaine C.; Loczenski-Brown, David M.; Loughna, Paul T.; Parr, Tim; Brameld, John M.

Response of the porcine MYH4-promoter and MYH4-expressing myotubes to known anabolic and catabolic agents in vitro Thumbnail


Authors

Madelaine C. Brearley

David M. Loczenski-Brown

Paul T. Loughna

TIM PARR TIM.PARR@NOTTINGHAM.AC.UK
Professor of Nutritional Biochemistry

Profile Image

JOHN BRAMELD JOHN.BRAMELD@NOTTINGHAM.AC.UK
Professor of Nutritional Biochemistry



Abstract

© 2021 The Authors Myosin heavy chain-IIB (MyHC-IIB; encoded by MYH4 or Myh4) expression is often associated with muscle hypertrophic growth. Unlike other large mammals, domestic pig breeds express MyHC-IIB at both the mRNA and protein level. Aim: To utilise a fluorescence-based promoter-reporter system to test the influence of anabolic and catabolic agents on increasing porcine MYH4-promoter activity and determine whether cell hypertrophy was subsequently induced. Methods: C2C12 myoblasts were co-transfected with porcine MYH4-promoter-driven ZsGreen and CMV-driven DsRed expression plasmids. At the onset of differentiation, treatments (dibutyryl cyclic-AMP (dbcAMP), Des(1–3) Insulin-Like Growth Factor-1 (IGF-I), triiodo-L-thyronine (T3) and dexamethasone (Dex)) or appropriate vehicle controls were added and cells maintained for up to four days. At day 4 of differentiation, measurements were collected for total fluorescence and average myotube diameter, as indicators of MYH4-promoter activity and cell hypertrophy respectively. Results: Porcine MYH4-promoter activity increased during C2C12 myogenic differentiation, with a marked increase between days 3 and 4. MYH4-promoter activity was further increased following four days of dbcAMP treatment and average myotube diameter was significantly increased by dbcAMP. Porcine MYH4-promoter activity also tended to be increased by T3 treatment, but there were no effects of Des(1–3) IGF-I or Dex treatment, whereas average myotube diameter was increased by Des(1–3) IGF-I, but not T3 or Dex. Conclusion: Porcine MYH4-promoter activity responded to dbcAMP, Des(1–3) IGF-I and T3 treatment in vitro as observed previously in reported in vivo studies. However, we report that increased MYH4-promoter activity was not always associated with muscle cell hypertrophy. The fluorescence-based reporter system offers a useful tool to study muscle cell hypertrophic growth.

Citation

Brearley, M. C., Loczenski-Brown, D. M., Loughna, P. T., Parr, T., & Brameld, J. M. (2021). Response of the porcine MYH4-promoter and MYH4-expressing myotubes to known anabolic and catabolic agents in vitro. Biochemistry and Biophysics Reports, 25, Article 100924. https://doi.org/10.1016/j.bbrep.2021.100924

Journal Article Type Article
Acceptance Date Jan 17, 2021
Online Publication Date Feb 2, 2021
Publication Date Mar 1, 2021
Deposit Date Feb 5, 2021
Publicly Available Date Feb 5, 2021
Journal Biochemistry and Biophysics Reports
Electronic ISSN 2405-5808
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 25
Article Number 100924
DOI https://doi.org/10.1016/j.bbrep.2021.100924
Public URL https://nottingham-repository.worktribe.com/output/5293791
Publisher URL https://www.sciencedirect.com/science/article/pii/S2405580821000182

Files





You might also like



Downloadable Citations